These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Energy metabolism in ALS: an underappreciated opportunity? Vandoorne T; De Bock K; Van Den Bosch L Acta Neuropathol; 2018 Apr; 135(4):489-509. PubMed ID: 29549424 [TBL] [Abstract][Full Text] [Related]
11. Association between estimated total daily energy expenditure and stage of amyotrophic lateral sclerosis. Lee J; Baek H; Kim SH; Park Y Nutrition; 2017 Jan; 33():181-186. PubMed ID: 27544003 [TBL] [Abstract][Full Text] [Related]
12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
13. Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice. Jaiswal MK; Keller BU Mol Pharmacol; 2009 Mar; 75(3):478-89. PubMed ID: 19060114 [TBL] [Abstract][Full Text] [Related]
14. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Genton L; Viatte V; Janssens JP; Héritier AC; Pichard C Clin Nutr; 2011 Oct; 30(5):553-9. PubMed ID: 21798636 [TBL] [Abstract][Full Text] [Related]